Agios to Present Broad Set of Clinical and Translational Data in Chronic Hemolytic Anemias at 63rd ASH Annual Meeting and Exposition Read more about Agios to Present Broad Set of Clinical and Translational Data in Chronic Hemolytic Anemias at 63rd ASH Annual Meeting and Exposition
Agios Reports Business Highlights and Third Quarter 2021 Financial Results Read more about Agios Reports Business Highlights and Third Quarter 2021 Financial Results
Agios to Webcast Conference Call of Third Quarter 2021 Financial Results on Nov. 3, 2021 Read more about Agios to Webcast Conference Call of Third Quarter 2021 Financial Results on Nov. 3, 2021
Agios at 2021 Cantor Virtual Global Healthcare Conference Read more about Agios at 2021 Cantor Virtual Global Healthcare Conference
Agios at Citi’s 16th Annual Biopharma Virtual Conference: Benign Hematology Panel Discussion Read more about Agios at Citi’s 16th Annual Biopharma Virtual Conference: Benign Hematology Panel Discussion
Agios To Present at September Investor Conferences Read more about Agios To Present at September Investor Conferences
Agios Announces FDA Acceptance and Priority Review of New Drug Application for Mitapivat for Treatment of Adults with Pyruvate Kinase Deficiency Read more about Agios Announces FDA Acceptance and Priority Review of New Drug Application for Mitapivat for Treatment of Adults with Pyruvate Kinase Deficiency
Agios Reports Business Highlights and Second Quarter 2021 Financial Results Read more about Agios Reports Business Highlights and Second Quarter 2021 Financial Results
Agios to Webcast Conference Call of Second Quarter 2021 Financial Results on July 29, 2021 Read more about Agios to Webcast Conference Call of Second Quarter 2021 Financial Results on July 29, 2021